Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin bags USFDA nod for generic equivalent of Edarbi Tablets

Ruchika Sharma25 Dec 2021 2:16 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug...

Roche at-home COVID rapid test gets USFDA approval

Ruchika Sharma25 Dec 2021 1:01 PM IST

Basel: Roche has recently announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization (EUA) for its...

Sucharita Rao Palepu appointed as Granules India independent director

Ruchika Sharma24 Dec 2021 1:22 PM IST

New Delhi: Drug maker, Granules india has recently announced the appointment of Mrs. Sucharita Rao Palepu as an Additional Director, categorized as...

Biocon arm gets DCGI nod to initiate clinical study for Itolizumab

Ruchika Sharma24 Dec 2021 1:13 PM IST

Itolizumab is a clinical-stage, first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6-ALCAM pathway.

Finally Molnupiravir gets USFDA nod

Ruchika Sharma24 Dec 2021 11:36 AM IST

Kenilworth: A day after Pfizer's Paxlovid bagged the U.S. Food and Drug Administration (USFDA) Emergency Use Authorization (EUA) nod, Merck's...

Pharma will give momentum in 2022, says OPPI

Ruchika Sharma24 Dec 2021 11:15 AM IST

New Delhi: Having contributed to the world during the challenging pandemic times by supplying 60 per cent of the global COVID-19 vaccine requirements,...

Covishield protection diminishes after 3 months: Lancet study

Ruchika Sharma24 Dec 2021 9:30 AM IST

London: The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive,...

Serum Institute waives indemnity over AstraZeneca COVID vaccine for refugees

Ruchika Sharma24 Dec 2021 9:00 AM IST

New Delhi: The Serum Institute of India (SII) has waived its protection from legal liabilities for any AstraZeneca-Oxford COVID-19 shots it supplies...

Booster dose of AstraZeneca COVID vaccine effective against Omicron

Ruchika Sharma23 Dec 2021 3:52 PM IST

UK: Citing the Oxford University lab study , drug major AstraZeneca has announced that the booster dose of the company's COVID vaccine Vaxzevria...

Hamdard Labs enters OTX segment, launches 13 new products

Ruchika Sharma23 Dec 2021 2:23 PM IST

New Delhi: Health and wellness firm Hamdard Laboratories on Monday said it has expanded its product portfolio with the introduction of 13 new products...

Pfizer COVID drug Paxlovid gets USFDA emergency use nod

Ruchika Sharma23 Dec 2021 12:54 PM IST

New York: Pfizer Inc. has recently announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID...

Serum Institute chief picks up 20 percent stake in Wakau

Ruchika Sharma23 Dec 2021 12:19 PM IST

New Delhi: Serum Institute of India (SII) Chief Adar Poonawaalla has picked up a 20 per cent stake in Wakau Interactive, a short-video sharing...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok